Meeting of the Advisory Commission on Childhood Vaccines, 112-113 [2019-28294]

Download as PDF 112 Federal Register / Vol. 85, No. 1 / Thursday, January 2, 2020 / Notices complies with the standards enumerated in the HOLA (12 U.S.C. 1467a(e)). Unless otherwise noted, comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors Ann E. Misback, Secretary of the Board, 20th Street and Constitution Avenue NW, Washington, DC 20551– 0001, not later than January 15, 2020. A. Federal Reserve Bank of Chicago (Colette A. Fried, Assistant Vice President) 230 South LaSalle Street, Chicago, Illinois 60690–1414: 1. 1895 Bancorp of Wisconsin, MHC, and 1895 Bancorp of Wisconsin, Inc., both of Greenfield, Wisconsin; a savings and loan holding company and a midtier savings and loan holding company, respectively, to engage de novo in holding, managing, or liquidating assets owned or acquired from a savings association, in connection with the transfer of branch property to 1895 Bancorp of Wisconsin, Inc. Board of Governors of the Federal Reserve System, December 26, 2019. Ann Misback, Secretary of the Board. [FR Doc. 2019–28281 Filed 12–31–19; 8:45 am] or the offices of the Board of Governors, Ann E. Misback, Secretary of the Board, 20th Street and Constitution Avenue NW, Washington, DC 20551–0001, not later than January 20, 2020. A. Federal Reserve Bank of Philadelphia (William Spaniel, Senior Vice President) 100 North 6th Street, Philadelphia, Pennsylvania 19105– 1521. Comments can also be sent electronically to Comments.applications@phil.frb.org: 1. The Toronto-Dominion Bank, Toronto, Ontario, Canada, and TD Group US Holdings, LLC, Wilmington, Delaware; to acquire equity securities of The Charles Schwab Corporation, San Francisco, California, and thereby indirectly acquire equity securities of its subsidiary savings associations, Charles Schwab Bank, Charles Schwab Premier Bank, and Charles Schwab Trust Bank, all of Henderson, Nevada, pursuant to section 4(c)(8) of the BHC Act. Board of Governors of the Federal Reserve System, December 26, 2019. Ann Misback, Secretary of the Board. [FR Doc. 2019–28280 Filed 12–31–19; 8:45 am] Washington DC 20551–0001, not later than January 30, 2020. A. Federal Reserve Bank of St. Louis (David L. Hubbard, Senior Manager) P.O. Box 442, St. Louis, Missouri 63166–2034. Comments can also be sent electronically to Comments.applications@stls.frb.org: 1. Reliable Community Bancshares, Inc., Perryville, Missouri; to acquire Bolivar Bancshares, Inc., and thereby indirectly acquire Bank of Bolivar, both of Bolivar, Missouri. In addition, Bolivar Acquisition Corp., Perryville, Missouri, to become a bank holding company by acquiring Bolivar Bancshares and thereby indirectly acquire Bank of Bolivar. Board of Governors of the Federal Reserve System, December 27, 2019. Ann Misback, Secretary of the Board. [FR Doc. 2019–28303 Filed 12–31–19; 8:45 am] BILLING CODE P DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE P Health Resources and Services Administration FEDERAL RESERVE SYSTEM Meeting of the Advisory Commission on Childhood Vaccines Formations of, Acquisitions by, and Mergers of Bank Holding Companies AGENCY: BILLING CODE P FEDERAL RESERVE SYSTEM lotter on DSKBCFDHB2PROD with NOTICES Notice of Proposals To Engage in or To Acquire Companies Engaged in Permissible Nonbanking Activities The companies listed in this notice have given notice under section 4 of the Bank Holding Company Act (12 U.S.C. 1843) (BHC Act) and Regulation Y, (12 CFR part 225) to engage de novo, or to acquire or control voting securities or assets of a company, including the companies listed below, that engages either directly or through a subsidiary or other company, in a nonbanking activity that is listed in § 225.28 of Regulation Y (12 CFR 225.28) or that the Board has determined by Order to be closely related to banking and permissible for bank holding companies. Unless otherwise noted, these activities will be conducted throughout the United States. Each notice is available for inspection at the Federal Reserve Bank indicated. The notice also will be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the question whether the proposal complies with the standards of section 4 of the BHC Act. Unless otherwise noted, comments regarding the applications must be received at the Reserve Bank indicated VerDate Sep<11>2014 17:39 Dec 31, 2019 Jkt 250001 The companies listed in this notice have applied to the Board for approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 1841 et seq.) (BHC Act), Regulation Y (12 CFR part 225), and all other applicable statutes and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below. The applications listed below, as well as other related filings required by the Board, if any, are available for immediate inspection at the Federal Reserve Bank indicated. The applications will also be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). Comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors, Ann E. Misback, Secretary of the Board, 20th Street and Constitution Avenue NW, PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS). ACTION: Notice. In accordance with the Federal Advisory Committee Act, this notice announces that the Advisory Commission on Childhood Vaccines (ACCV) will hold public meetings for the 2020 calendar year (CY). Information about ACCV, agendas, and materials for these meetings can be found on the ACCV website at https:// www.hrsa.gov/advisory-committees/ vaccines/index.html. DATES: ACCV meetings will be held on: • March 5–6, 2020; • June 4–5, 2020; • September 3–4, 2020; and • December 3–4, 2020. These meetings will be held from 9:00 a.m.–5:00 p.m. Eastern Time. ADDRESSES: Meetings may be held inperson, by teleconference, and/or Adobe Connect webinar. In-person ACCV meetings will be held at 5600 Fishers Lane, Rockville, Maryland 20857. Instructions for joining the meetings either in-person or remotely will be posted on the ACCV website 30 business days before the date of the meeting. For meeting information SUMMARY: E:\FR\FM\02JAN1.SGM 02JAN1 lotter on DSKBCFDHB2PROD with NOTICES Federal Register / Vol. 85, No. 1 / Thursday, January 2, 2020 / Notices updates, go to the ACCV website at https://www.hrsa.gov/advisorycommittees/vaccines/index.html. FOR FURTHER INFORMATION CONTACT: Annie Herzog, Division of Injury Compensation Programs, HRSA, 5600 Fishers Lane, 08N186B, Rockville, Maryland 20857; 301–443–6634; or aherzog@HRSA.gov. SUPPLEMENTARY INFORMATION: The ACCV provides advice and recommendations to the Secretary of HHS on policy, program development, and other issues related to implementation of the National Vaccine Injury Compensation Program (VICP) and concerning other matters as described under section 2119 of the Public Health Service Act (42 U.S.C. 300aa–19). Agenda items and meeting times are subject to change as priorities dictate. Refer to the ACCV website listed above for any meeting updates that may occur. For CY 2020 meetings, agenda items may include, but are not limited to updates from: (1) The Division of Injury Compensation Programs; (2) Department of Justice; (3) Office of Infectious Disease and HIV/AIDS Policy (HHS); (4) Immunization Safety Office (Centers for Disease Control and Prevention); (5) National Institute of Allergy and Infectious Diseases (National Institutes of Health); and, (6) Center for Biologics, Evaluation and Research (Food and Drug Administration). Refer to the ACCV website listed above for all current and updated information concerning the CY 2020 ACCV meetings, including draft agendas and meeting materials that will be posted 5 calendar days before the meeting. Members of the public will have the opportunity to provide comments. Public participants may submit written statements in advance of the scheduled meeting(s). Oral comments will be honored in the order they are requested and may be limited as time allows. Requests to submit a written statement or make oral comments to ACCV should be sent to Annie Herzog using the contact information above at least 5 business days before the meeting date(s). Individuals who need special assistance or another reasonable accommodation should notify Annie Herzog using the contact information listed above at least 10 business days before the meeting(s) they wish to attend. Since all in person meetings will occur in a federal government building, attendees must go through a security check to enter the building. Non-U.S. Citizen attendees must notify HRSA of their planned attendance at least 20 business days prior to the meeting in VerDate Sep<11>2014 17:39 Dec 31, 2019 Jkt 250001 order to facilitate their entry into the building. All attendees are required to present government-issued identification prior to entry. Maria G. Button, Director, Executive Secretariat. [FR Doc. 2019–28294 Filed 12–31–19; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF THE INTERIOR Office of the Secretary [XXXD5198NI DS61100000 DNINR0000.000000 DX61104] Exxon Valdez Oil Spill Public Advisory Committee; Call for Nominations Office of the Secretary, Interior. Notice. AGENCY: ACTION: The Exxon Valdez Oil Spill Trustee Council is soliciting nominations for the Public Advisory Committee to fill three membership vacancies that represent sport hunting/ fishing, science/technology, and conservation/environmental interests. The Public Advisory Committee advises the Trustee Council on decisions related to the planning, evaluation, funds allocation, and conduct of injury assessment and restoration activities related to the T/V Exxon Valdez oil spill of March 1989. Public Advisory Committee members will be selected and appointed by the Secretary of the Interior to serve a two-year term. DATES: All nominations must be received by February 3, 2020. ADDRESSES: A complete nomination package should be submitted by hard copy or via email to Elise Hsieh, Executive Director, Exxon Valdez Oil Spill Trustee Council, 4230 University Drive, Suite 220, Anchorage, Alaska 99508–4650, or at elise.hsieh@ alaska.gov. Also please copy Shiway Wang, Science Director, on any correspondence, at shiway.wang@ alaska.gov. SUMMARY: FOR FURTHER INFORMATION CONTACT: Questions should be directed to Cherri Womac, Exxon Valdez Oil Spill Trustee Council, 4230 University Drive, Suite 220, Anchorage, Alaska 99508–4650, (907) 278–8012 or (800) 478–7745 or via email at cherri.womac@alaska.gov; or Dr. Philip Johnson, Designated Federal Officer, U.S. Department of the Interior, Office of Environmental Policy and Compliance, 1689 C Street, Suite 119, Anchorage, Alaska 99501–5126, (907) 271–5011. SUPPLEMENTARY INFORMATION: The Exxon Valdez Oil Spill Public Advisory PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 113 Committee was created by Paragraph V.A.4 of the Memorandum of Agreement and Consent Decree entered into by the United States of America and the State of Alaska on August 27, 1991, and approved by the United States District Court for the District of Alaska in settlement of United States of America v. State of Alaska, Civil Action No. A91–081 CV. The Public Advisory Committee was created to advise the Trustee Council on matters relating to decisions on injury assessment, restoration activities, or other use of natural resource damage recoveries obtained by the government. The Trustee Council consists of representatives of the U.S. Department of the Interior, U.S. Department of Agriculture, National Oceanic and Atmospheric Administration, Alaska Department of Fish and Game, Alaska Department of Environmental Conservation, and Alaska Department of Law. The Public Advisory Committee consists of 10 members to reflect balanced representation from each of the following principal interests: Aquaculture/mariculture, commercial tourism, conservation/environmental, recreation, subsistence use, commercial fishing, native landownership, sport hunting/fishing, science/technology, and public-at-large. Nominations for membership may be submitted by any source. Nominations should include a re´sume´ providing an adequate description of the nominee’s qualifications, including information that would enable the Department of the Interior to make an informed decision regarding meeting the membership requirements of the Public Advisory Committee and permit the Department of the Interior to contact a potential member. Authority: 5 U.S.C. Appendix 2. Philip Johnson, Regional Environmental Officer, Office of Environmental Policy and Compliance. [FR Doc. 2019–28284 Filed 12–31–19; 8:45 am] BILLING CODE 4334–63–P DEPARTMENT OF THE INTERIOR National Park Service [NPS–WASO–NRNHL–DTS#–29524; PPWOCRADI0, PCU00RP14.R50000] National Register of Historic Places; Notification of Pending Nominations and Related Actions National Park Service, Interior. Notice. AGENCY: ACTION: E:\FR\FM\02JAN1.SGM 02JAN1

Agencies

[Federal Register Volume 85, Number 1 (Thursday, January 2, 2020)]
[Notices]
[Pages 112-113]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-28294]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Meeting of the Advisory Commission on Childhood Vaccines

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, this 
notice announces that the Advisory Commission on Childhood Vaccines 
(ACCV) will hold public meetings for the 2020 calendar year (CY). 
Information about ACCV, agendas, and materials for these meetings can 
be found on the ACCV website at https://www.hrsa.gov/advisory-committees/vaccines/index.html.

DATES: ACCV meetings will be held on:
     March 5-6, 2020;
     June 4-5, 2020;
     September 3-4, 2020; and
     December 3-4, 2020.
    These meetings will be held from 9:00 a.m.-5:00 p.m. Eastern Time.

ADDRESSES: Meetings may be held in-person, by teleconference, and/or 
Adobe Connect webinar. In-person ACCV meetings will be held at 5600 
Fishers Lane, Rockville, Maryland 20857. Instructions for joining the 
meetings either in-person or remotely will be posted on the ACCV 
website 30 business days before the date of the meeting. For meeting 
information

[[Page 113]]

updates, go to the ACCV website at https://www.hrsa.gov/advisory-committees/vaccines/index.html.

FOR FURTHER INFORMATION CONTACT: Annie Herzog, Division of Injury 
Compensation Programs, HRSA, 5600 Fishers Lane, 08N186B, Rockville, 
Maryland 20857; 301-443-6634; or [email protected].

SUPPLEMENTARY INFORMATION: The ACCV provides advice and recommendations 
to the Secretary of HHS on policy, program development, and other 
issues related to implementation of the National Vaccine Injury 
Compensation Program (VICP) and concerning other matters as described 
under section 2119 of the Public Health Service Act (42 U.S.C. 300aa-
19).
    Agenda items and meeting times are subject to change as priorities 
dictate. Refer to the ACCV website listed above for any meeting updates 
that may occur. For CY 2020 meetings, agenda items may include, but are 
not limited to updates from: (1) The Division of Injury Compensation 
Programs; (2) Department of Justice; (3) Office of Infectious Disease 
and HIV/AIDS Policy (HHS); (4) Immunization Safety Office (Centers for 
Disease Control and Prevention); (5) National Institute of Allergy and 
Infectious Diseases (National Institutes of Health); and, (6) Center 
for Biologics, Evaluation and Research (Food and Drug Administration). 
Refer to the ACCV website listed above for all current and updated 
information concerning the CY 2020 ACCV meetings, including draft 
agendas and meeting materials that will be posted 5 calendar days 
before the meeting.
    Members of the public will have the opportunity to provide 
comments. Public participants may submit written statements in advance 
of the scheduled meeting(s). Oral comments will be honored in the order 
they are requested and may be limited as time allows. Requests to 
submit a written statement or make oral comments to ACCV should be sent 
to Annie Herzog using the contact information above at least 5 business 
days before the meeting date(s).
    Individuals who need special assistance or another reasonable 
accommodation should notify Annie Herzog using the contact information 
listed above at least 10 business days before the meeting(s) they wish 
to attend. Since all in person meetings will occur in a federal 
government building, attendees must go through a security check to 
enter the building. Non-U.S. Citizen attendees must notify HRSA of 
their planned attendance at least 20 business days prior to the meeting 
in order to facilitate their entry into the building. All attendees are 
required to present government-issued identification prior to entry.

Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2019-28294 Filed 12-31-19; 8:45 am]
 BILLING CODE 4165-15-P